Stay updated with breaking news from High Acuity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Amedisys, Inc. (NASDAQ:AMED – Get Rating) have been given a consensus recommendation of “Hold” by the seventeen ratings firms that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and eight have given a buy recommendation to […]
Investment analysts at Cantor Fitzgerald initiated coverage on shares of Amedisys (NASDAQ:AMED – Get Rating) in a note issued to investors on Thursday, The Fly reports. The brokerage set a “neutral” rating on the health services provider’s stock. AMED has been the topic of several other reports. StockNews.com raised shares of Amedisys from a “hold” […]
Cambiar Investors LLC raised its stake in Amedisys, Inc. (NASDAQ:AMED – Get Rating) by 38.3% during the 4th quarter, Holdings Channel reports. The fund owned 85,249 shares of the health services provider’s stock after acquiring an additional 23,620 shares during the period. Cambiar Investors LLC’s holdings in Amedisys were worth $7,122,000 as of its most […]
Leeward Investments LLC MA lessened its stake in Amedisys, Inc. (NASDAQ:AMED – Get Rating) by 4.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 137,817 shares of the health services provider’s stock after selling 6,274 shares during the quarter. Leeward […]
Amedisys (NASDAQ:AMED – Get Rating) had its target price lowered by Truist Financial from $130.00 to $115.00 in a research note published on Thursday, The Fly reports. Other equities research analysts have also recently issued reports about the stock. Benchmark reissued a buy rating and issued a $115.00 target price on shares of Amedisys in […]